Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C5H7N |
| Molecular Weight | 81.1158 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C1C=CNC=C1
InChI
InChIKey=YNGDWRXWKFWCJY-UHFFFAOYSA-N
InChI=1S/C5H7N/c1-2-4-6-5-3-1/h2-6H,1H2
| Molecular Formula | C5H7N |
| Molecular Weight | 81.1158 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Stereoselective trans- and cis-dihydroxylations of 2H-pyranyl and dihydropyridinyl heterocycles synthesized from formal [3 + 3]-cycloaddition reactions of alpha,beta-unsaturated iminium ions with 1,3-dicarbonyl equivalents. | 2001 Jul 12 |
|
| Productive trapping of NAD-type radicals. Non-biomimetic reduction of pyridinium salts. | 2002 Apr 21 |
|
| Selective glucocorticoid receptor nonsteroidal ligands completely antagonize the dexamethasone mediated induction of enzymes involved in gluconeogenesis and glutamine metabolism. | 2004 Dec |
|
| Oxidation of C4-hydroxyphenyl 1,4-dihydropyridines in dimethylsulfoxide and its reactivity towards alkylperoxyl radicals in aqueous medium. | 2007 Jun 15 |
|
| Synthesis, coordination chemistry and bonding of strong N-donor ligands incorporating the 1H-pyridin-(2E)-ylidene (PYE) motif. | 2009 Oct 26 |
|
| Exceptional thermal stability in a supramolecular organic framework: porosity and gas storage. | 2010 Oct 20 |
|
| Cystic fibrosis: a new target for 4-Imidazo[2,1-b]thiazole-1,4-dihydropyridines. | 2011 Jun 9 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:12:18 GMT 2023
by
admin
on
Fri Dec 15 18:12:18 GMT 2023
|
| Record UNII |
7M8K3P6I89
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
50075
Created by
admin on Fri Dec 15 18:12:18 GMT 2023 , Edited by admin on Fri Dec 15 18:12:18 GMT 2023
|
PRIMARY | |||
|
C038806
Created by
admin on Fri Dec 15 18:12:18 GMT 2023 , Edited by admin on Fri Dec 15 18:12:18 GMT 2023
|
PRIMARY | |||
|
Dihydropyridine
Created by
admin on Fri Dec 15 18:12:18 GMT 2023 , Edited by admin on Fri Dec 15 18:12:18 GMT 2023
|
PRIMARY | |||
|
104822
Created by
admin on Fri Dec 15 18:12:18 GMT 2023 , Edited by admin on Fri Dec 15 18:12:18 GMT 2023
|
PRIMARY | |||
|
7M8K3P6I89
Created by
admin on Fri Dec 15 18:12:18 GMT 2023 , Edited by admin on Fri Dec 15 18:12:18 GMT 2023
|
PRIMARY | |||
|
DTXSID20274185
Created by
admin on Fri Dec 15 18:12:18 GMT 2023 , Edited by admin on Fri Dec 15 18:12:18 GMT 2023
|
PRIMARY | |||
|
100000142184
Created by
admin on Fri Dec 15 18:12:18 GMT 2023 , Edited by admin on Fri Dec 15 18:12:18 GMT 2023
|
PRIMARY | |||
|
3337-17-5
Created by
admin on Fri Dec 15 18:12:18 GMT 2023 , Edited by admin on Fri Dec 15 18:12:18 GMT 2023
|
PRIMARY | |||
|
SUB115812
Created by
admin on Fri Dec 15 18:12:18 GMT 2023 , Edited by admin on Fri Dec 15 18:12:18 GMT 2023
|
PRIMARY |